Medical/Pharmaceuticals
Travelers from Singapore Can Now Access 24/7 Multilingual Online Doctor Consultations in Japan -- M3 Career's HOTEL de DOCTOR 24 Provides Peace of Mind During Unexpected Illness
TOKYO, Nov. 13, 2025 /PRNewswire/ -- HOTEL de DOCTOR 24, a specialized online medical consultation service provided by M3 Career, Inc., offers seamless 24-hour access to healthcare for international travelers facing difficulties obtaining medical care inJapan. While HOTEL de DOCTOR 24 has been av...
2025-11-13 15:00
2220
Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research
Research focuses on human cardiac organoids to uncover metabolic drivers of
heart failure and accelerate new therapeutic strategies to improve
cardiovascular outcomes
SINGAPORE, Nov. 13, 2025 /PRNewswire/ -- Agilent Technologies Inc.
2025-11-13 12:05
2202
Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development
- Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist, demonstrated a comparable pharmacokinet...
2025-11-13 07:30
3352
Laronix Secures $3.2 Million Grant from the Australian Government to Bring its AI-Powered Voice Technology to the Market
BRISBANE, Australia, Nov. 13, 2025 /PRNewswire/ -- Laronix
2025-11-13 06:30
2443
Focusing on Industrialisation and Exploring Global Pathways -- The 3rd CREATE Symposium Concludes Successfully
HONG KONG, Nov. 12, 2025 /PRNewswire/ -- How is artificial intelligence revolutionising diagnostic experiences? How can robotics enhance surgical precision? How far are we from achieving universal access to medical AI? What are the latest trends and future directions in medical technology develo...
2025-11-12 21:20
1934
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A
TAIPEI, Nov. 12, 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosim...
2025-11-12 16:12
1719
Vieworks Completes Major Expansion of Hwaseong Manufacturing Site, Doubling Production Capacity
Strategic Infrastructure Growth Positions Vieworks at the Forefront of Global Imaging Innovation ANYANG, South Korea, Nov. 12, 2025 /PRNewswire/ -- Vieworks, a global leader in advanced X-ray imaging and industrial vision systems, has announced the successful completion of a large-scale expansio...
2025-11-12 10:44
3725
Alpha IVF Singapore uses Advanced Fertility Genomic Screening and Artificial Intelligence Embryo Scoring to help couples become parents
SINGAPORE, Nov. 12, 2025 /PRNewswire/ -- In-vitro fertilisation (IVF) has become increasingly prominent due to societal shifts towards delayed childbearing, infertility issues, and advances in medical technology that have improved success rates. At Alpha IVF Singapore, Advanced Fertility Genomic ...
2025-11-12 10:00
1681
John Chuang and Onyx Healthcare Inc. Honored with Dual Wins at the Asia Pacific Enterprise Awards (APEA) 2025 Taiwan Chapter
TAIPEI, Nov. 12, 2025 /PRNewswire/ -- Onyx Healthcare Inc., a global leader in medical AI computing and healthcare device manufacturing, proudly celebrates its dual victory at the Asia Pacific Enterprise Awards (APEA) 2025 Taiwan Chapter, receiving accolades under the Corporate Excellence and Mas...
2025-11-12 09:00
1336
OPALESCENCE Trial Published in EJNMMI: Confirms Theranostic Potential of TLX250-CDx in Breast Cancer
MELBOURNE, Australia and INDIANAPOLIS, Nov. 12, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that final positive results from the Phase 2 OPALESCENCE trial[1] of TLX250-CDx (89 Zr-girentuximab) in metastatic triple negative breast cancer (mTNB...
2025-11-12 04:00
2538
Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments
VALBY, Denmark, Nov. 12, 2025 /PRNewswire/ -- Key highlights Lundbeck's total revenue grew by +14% CER[1] (+13% DKK) to DKK 18,537 million in the first nine months of 2025. Growth in the U.S. andEurope was the driver of this strong performance. * United States: DKK 9,955 million (+22% CER; +19...
2025-11-12 03:11
2649
The Sigourney Award-2025 Celebrates Four Recipients Honored for Creative Trailblazing Work Expanding Psychoanalytic Thought Globally
Interdisciplinary Work from Israel, Uruguay, and the United States Earns The Prestigious Sigourney Award-2025 Prize SAN FRANCISCO, Nov. 11, 2025 /PRNewswire/ -- The trailblazing work of four recipients has won The Sigourney Award-2025, earning international recognition and a substantial cash pri...
2025-11-11 21:11
2018
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at theAssociation for Molecular Pa...
2025-11-11 21:01
1551
Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software
* Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography Data System (CDS). * Mitigates CDS communication errors encountered in up to 70% of multi-vendor LC-CAD configurations.1 * Delivers near-unive...
2025-11-11 21:00
2427
Apollo Cancer Centres Turns Chocolates into Health Reminders with 'Check-Olate'
NEW DELHI, Nov. 11, 2025 /PRNewswire/ -- To observe this year's Breast Cancer Awareness Month, Apollo Cancer Centres (ACCs) recently launched acrossIndia a unique initiative that blended indulgence with awareness through'Check-Olate', a sweet treat that carries an even sweeter reminder: take a mo...
2025-11-11 17:15
1479
Guo Guangchang: Fosun Strengthens Globalization Capabilities, Accelerates Innovation through Open Cooperation
HONG KONG, Nov. 11, 2025 /PRNewswire/ -- On 8 November, Guo Guangchang, Chairman of Fosun International, attended the 3rd Pujiang Biopharmaceutical Original Innovation Conference 2025. During the conference, Guo Guangchang stated, "At this crucial juncture today,China's pharmaceutical innovation ...
2025-11-11 15:41
4338
OMNIBOT Showcases How Connectivity Expands Possibilities in Live Telesurgery at Chilean Urology Congress
-The live telesurgery took place during the XLVI Annual Congress of the Chilean Society of Urology, which also marked the Society's 100th anniversary. This procedure highlights how network connectivity is enabling new forms of surgical collaboration. SINGAPORE, Nov. 11, 2025 /PRNewswire/ -- Duri...
2025-11-11 13:00
2123
Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices
RAICHUR, India, Nov. 11, 2025 /PRNewswire/ -- Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), has been awarded the prestigiousGold Medal by EcoVadis, the world's most trusted provider of business sustainability ratings. The com...
2025-11-11 09:15
2507
Shilpa Medicare Announces Positive Phase 3 Results for OERIS™ -- A Novel Once-Weekly Ondansetron Extended-Release Injection for Chemotherapy-Induced Nausea and Vomiting (CINV)
Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections RAICHUR, India, Nov. 11, 2025 /PRNewswire/ -- Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) announced the successfu...
2025-11-11 09:00
2043
Vexev's VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics
* VxWave Ultrasound Imaging System demonstrated 94% scanning success rate and 100% data adequacy rate for vascular access creation strategies in CANSCAN trial * New insights into vascular anatomy made possible by standardized image acquisition and reporting * VxWave System has the potential t...
2025-11-11 05:32
2193
Week's Top Stories
Most Reposted
CityUHK and University of Cambridge establish Centre for Advanced and Smart Manufacturing to shape Hong Kong's Industry 5.0 future
[Picked up by 293 media titles]
2026-09-22 18:37
Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 292 media titles]
2026-09-24 10:30
CGS International Convenes China-ASEAN Business Leaders Summit to Deepen Capital Connectivity Across the Corridor
[Picked up by 281 media titles]
2026-09-23 09:00
01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
[Picked up by 277 media titles]
2026-09-21 08:00Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 275 media titles]
2026-09-25 14:45
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
12355
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
11067
Dreame Technology Opens New Flagship Store at Suntec City, Expanding Smart Living Experience in Singapore
2026-09-25 18:33
9998
